High-grade serous ovarian cancer is an aggressive form of epithelial ovarian cancer (EOC), and accounts for the majority of deaths due to EOC. The critical cellular processes and underlying molecular mechanisms that define this malignancy remain poorly understood. Using a syngeneic murine model, we investigated the changes that accompanied the progression to increased aggressiveness induced by in vivo passage of mouse EOC cells. We found that enhanced anoikis resistance was a key cellular process associated with greater aggressiveness and tumorigenicity in vivo. Biochemical studies revealed that the enhanced anoikis resistance was associated with the activation of the Src/Akt/Erk signaling pathway. A higher rate of metabolism and autophagy were also associated with increased anoikis resistance. Blocking these pathways with specific inhibitors and/or genetic modifications significantly increased anoikis in vitro and inhibited tumor development in vivo. In addition, we demonstrated that similar signaling pathways were also involved in a human EOC cell line model. Collectively, our data suggest that anoikis resistance represents a critical and a distinguishing feature underlying the aggressiveness of ovarian cancer cells.
INTRODUCTION
Epithelial ovarian cancer (EOC) is the most deadly gynecologic disease. Over 70% of patients with EOC are diagnosed at advanced stages, characterized by massive ascites containing large numbers of tumor cells. These suspended tumor cells are shed from primary ovarian tumors, and then attach and invade the mesothelium of the peritoneal wall (PW) and other organs, forming secondary lesions throughout the peritoneal cavity. At this stage the disease is very difficult to treat, and only temporary remission can be achieved with chemotherapy. Patients commonly die of abdominal metastases; extra-abdominal metastasis is rare, a fact that reflects the unique behavior of EOC cells.
The gene signatures and main signaling pathways involved in EOC have been extensively investigated via high-throughput and integrated studies. 1 However, identification of the oncogenic driver genes of EOC requires function-directed approaches. To search for relevant driver genes, we sought to examine the change in aggressiveness that results from in vivo passage of mouse EOC cells in a syngeneic mouse model. Compared with using human EOC cell lines in a xenograft model, this approach offered an immune-competent microenvironment to yield more pathologically relevant findings.
The ID8 cell line was obtained through spontaneous transformation of normal ovarian surface epithelial cells from C57BL6 mice by repetitive passage in vitro. In vivo, intraperitoneally (i.p.) injected ID8 cells produce tumors very similar to human high-grade serous ovarian cancer, with similar oncogenic signaling pathways. Importantly, ID8 cells produce tumors in immune-intact mice, which allows the study of the tumor microenvironment and tumor-host interactions. The i.p.-injected ID8 cells preferentially metastasize to the diaphragm (DP), PW, mesentery and omentum (OM). [2] [3] [4] We observed that daughter cells lines established from these tumors display increased aggressiveness upon reinjection into naive mice, as defined by the time to onset of tumor/ascites formation and morbidity in the mouse model. To identify the cellular processes that are critically involved in the increased aggressiveness observed in our model, we conducted functiondirected cellular and biological analyses in vivo and in vitro. We compared the behavior and characteristics of the parent and daughter cell lines, and then focused on the signaling pathways controlling the differences in cell functions to understand the molecular mechanisms underlying the increased aggressiveness of the daughter cells.
RESULTS
In vivo passage of ID8 cells resulted in greatly increased aggressiveness Following i.p. injection of ID8-luc (ID8 cells expressing luciferase, termed ID8-P0) cells into C57BL6 mice, tumors and ascites developed in~90 days. Tumor cells isolated from tumor nodules on the diaphragm, PW, mesentery, OM, liver, kidney and floating cells in ascites were cultured in vitro. Their tumorigenic capacities were tested. All of these P1 cell lines displayed markedly enhanced tumorigenic/metastatic potency. Time to tumor/ascites formation was reduced from 90 days to 22-45 days. In addition, the P1 cells obtained from different organs did not show significant differences in organ specificity. Regardless of where P1 cells were collected, they had similar preference to OM when they were reinjected. Thus, we used PW-P1 (ID8-P1) cells as representative P1 cells for the most of the functional studies conducted in this work.
The mouse morbidity times were also changed: seven of 10 mice injected with ID8-P1 cells died at 21-24 days post injection, and all died by 28 days, whereas mice injected with ID8-P0 cells died between 80 and 110 days post injection (Figure 1a) . The number of tumor metastases on peritoneal organs increased markedly in mice injected with ID8-P1 as compared with ID8-P0 cells (Figures 1b and  c) . Thus, the ID8-P1 cell line represents a model of greatly increased aggressiveness, as compared with ID8-P0.
ID8-P1 cells exhibited enhanced anoikis resistance in vivo
To determine the differences between ID8-P0 and ID8-P1 tumors, we first performed immunohistochemical analyses on tumor sections. There were no significant differences in the expression of Ki67 (a cell proliferation marker, Figure 2a ), CD31 (vessel formation) or F4/80 (macrophage infiltration) staining between ID8-P0 and ID8-P1 tumors (data not shown), suggesting that ID8-P1 cells did not gain increased proliferative or angiogenic abilities once the solid tumors were formed.
We postulated that the potently increased aggressiveness of ID8-P1 cells was related to early-stage tumor cells survival and/or the ability of migration and invasion in the peritoneal cavity. To test these hypotheses, we first counted and compared living tumor cells (expressing green fluorescent protein (GFP)) by collecting peritoneal washings on selected days post i.p. injection (n ⩾ 3 mice per time point). As shown in Figure 2b , there were~50-fold more surviving ID8-P1 cells than ID8-P0 cells on days 5 and 10. The recovered living cells on day 5 were 30% of the number of ID8-P1 cells injected (GFP-positive cells;~1. 5 × 10 6 ), compared with only about 0.6% (~3 × 10 4 ) of the injected ID8-P0 cell number at the same time point. The mice injected with ID8-P1 cells succumbed around 24 days post injection. In the mice injected with ID8-P0 cells, the number of peritoneal tumor cells increased from day 5 to day 75, when solid tumors and/or ascites become evident. These data suggest that the ID8-P1 cells have acquired an enhanced ability to resist anoikis after in vivo passage, and that floating-cell survival in the peritoneal cavity after i.p. injection, which mimics early-stage tumor cell dissemination of EOC, is critical for aggressiveness of tumor progression.
To compare the ability to attach and invade peritoneal organ sites, we examined tumor metastases on OM, diaphragm, PW, liver, kidney, intestine and adipose tissue for GFP fluorescence under a dissecting microscope. We found that the OM was the favored tissue for metastasis for both ID8-P0 and ID8-P1 cells. The OM showed GFP fluorescence (derived from tumor cells) above background at 1 day post injection, when there was no detectable fluorescence in other organs (Figures 2c and d and data not shown). However, the attachment and/or invasion of tumor cells to OM were not significantly different between ID8-P0 and ID8-P1 cells in the first 10 days post injection, suggesting that ID8-P1 cells did not acquire stronger cell adhesion and/or invasion ability at an early stage, and that the higher number of surviving floating tumor cells are likely to account for the early onset of solid tumor development. ID8-P1 cells were more resistant to anoikis in vitro Anoikis assays in low-attachment poly-(2-hydroxyethyl methacrylate) (poly-HEMA)-coated plates were used to test cell survival in a suspended condition. 5 After 3 days in serum-free medium,~40% of ID8-P1 cells, but ⩽ 5% of ID8-P0 cells survived (Figure 3a) . After 3 days in 5% fetal bovine serum (FBS), about 75% of ID8-P1 and 25% of ID8-P0 cells survived, respectively (Figure 3b ). Anoikis resistance is necessary for anchorage-independent growth. 6 Colony formation was three-fold greater for ID8-P1 cells than for ID8-P0 cells (101 ± 5 vs 23 ± 3, Figure 3c ). Reduced apoptosis in ID8-P1 cells as compared with ID8-P0 cells was supported by reduced activation of caspase-3, as detected in a western blot for cleaved caspase-3 ( Figure 3d ). This difference could be detected only in suspended cells. No caspase-3 activation (cleavage) was detected in either ID8-P0 or ID8-P1 when cells were attached (Figure 3d) . Interestingly, when cells were cultured in standard two-dimensional cell culture dishes, no significant difference in cell proliferation was observed between ID8-P0 and ID8-P1 cells using 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays, but ID8-P1 cells had a tendency to have lower cell numbers (Figure 3e ). Flow cytometric analyses of cell cycles were also used to investigate whether there was a difference between ID8-P0 and ID8-P1 in cell cycle progression cultured in two-dimensional cell culture dishes. The percentages of ID8-P0 cells in G1, S and G2\M stages were 46.5 ± 1.5%, 9.2 ± 1.1% and 34.5 ± 1.1%, respectively. The percentages of ID8-P1 cells in G1, S and G2\M stages were 50.3 ± 2.3%, 11.6 ± 1.4% and 28.5 ± 3.2%, respectively ( Figure 3g ). These differences are not statistically significant. These results are consistent with our in vivo Ki67-staining data, supporting that ID8-P1 cells did not have increased proliferative capacity when cells were associated with matrix. We also compared cell migration using Boyden chamber (Tewksbury, MA, USA) transwell assays and found no significant difference between P0 and P1 cells (Figure 3e ). These results were consistent with our observations in mice that increased attachment of ID8-P1 cells to peritoneal organs at an early stage was not observed. Together, these results suggest that increased anoikis resistance was likely to be the most relevant and important feature acquired by ID8-P1 cells after in vivo passaging.
Src/Akt/Erk signaling was necessary and sufficient for increased anoikis resistance To elucidate the molecular mechanisms by which ID8-P1 cells gained anoikis resistance, we examined survival signaling pathways. Src/Akt/Erk signaling is a key mediator of cell survival. 7 Western blot analyses showed that when cells were grown under adherent conditions, there were no obvious differences in activated (phosphorylated) Src, Akt or Erk between ID8-P0 and ID8-P1 cells (Figure 4a ). However, when cells were grown under suspended conditions, Src, Akt and Erk were highly activated in ID8-P1 cells, as compared with ID8-P0 cells, in the absence or presence of FBS (Figure 4a ).
To show that these molecules were functionally involved in anoikis, we used small interfering RNA (for Src) and/or selective inhibitors (PP2 for Src; MK2206 for Akt; and PD98059 for Erk). All reduced the cell survival rate when ID8-P1 cells were cultured in suspension ( Figure 4b ). These inhibitors also significantly reduced the colony-forming ability of ID8-P1 cells (Figure 4c ). In vivo, PP2 reduced the number of surviving ID8-P1 cells in the mouse peritoneal cavity at day 5 post injection from~1.5 million to~0.08 million, a level similar to that seen for ID8-P0 cells. These data strongly suggest that enhanced Src activation is a crucial factor in the aggressiveness of ID8-P1 cells (Figure 4d ). We further tested the involvement of Src in anoikis resistance by the overexpression of constitutively active Src (CA-Src) in ID8-P0 cells. The increased pSrc level in ID8-P0 cells was verified by western blot analysis (Figure 4e ). Colony formation and anoikis assays showed that overexpression of CA-Src in ID8-P0 increased anchorage-independent growth and cell survival in suspension (Figures 4f and g ). In addition, increased Src signaling led to more surviving floating ID8-P0 cells in the mouse peritoneal cavity at day 5 post injection ( Figure 4h ). Therefore, Src signaling appeared to be necessary and sufficient for increased anoikis resistance in ID8 cells both in vitro and in vivo.
Metabolism and autophagy were important for anoikis resistance in ID8-P1 cells Cells can be rescued from anoikis by enhanced metabolism, which is regulated by Akt signaling. 8 We tested whether increased anoikis resistance in ID8-P1 cells was related to changes in cellular metabolism. The ATP level was substantially higher in ID8-P1 cells, as compared with that of ID8-P0 cells (Figure 5a ). Consistently, ID8-P1 cells consumed twofold more glucose than ID8-P0 cells (3.9 ± 0.3 mmol vs 1.5 ± 0.2 mmol; Figure 5b ). In addition, ID8-P1 cells produced more lactate than ID8-P0 cells in culture medium (Figure 5c ). Besides the mitochondrial oxidative phosphorylation pathway, cancer cells have adapted to derive a significant amount of their ATP from converting glucose to lactate, a process termed the Warburg effect. 9 We checked whether the increased metabolic rate in ID8-P1 cells was dependent on the mitochondrial pathway or glycolysis by using the mitochondrial complex 1 inhibitor rotenone, glycolysis inhibitor 2-deoxyglucose and lactate dehydrogenase A inhibitor oxamate. 8, 10 As shown in Figures 5a and c, blocking of mitochondrial pathway and glycolysis both significantly decreased the ATP level and lactate secretion in ID8-P1 cells, indicating ID8-P1 cells used both pathways to maintain a high metabolic rate.
To explore the functional importance of enhanced metabolism in ID8-P1 cells, we cultured both ID8-P0 and ID8-P1 in glucose-free medium in low-attachment plates. As shown in Figure 5d , the survival rate of ID8-P1 cells decreased markedly in glucose-free medium, whereas the survival rate of ID8-P0 cells was only slightly affected, indicating that the anoikis resistance of ID8-P1 cells was glucose dependent. Glucose is transported from extracellular spaces into cells by glucose transporters, and mainly via Glut-1 in cancer cells. Western blot analyses showed that the Glut-1 level was elevated in ID8-P1 as compared with ID8-P0 cells (Figure 5e ). Ectopic expression of CA-Src in ID8-P0 cells increased Glut-1 expression in these cells, suggesting Src is an important regulator of Glut-1 (Figure 5e ).
Given the important role of autophagy in tumor cell metabolism and enhanced energy production, we examined the levels of LC3B (a marker of autophagy) in ID8-P1 cells.
Indeed, LC3B was greatly elevated in ID8-P1 cells (Figure 6a ). To test the functional importance of the autophagic pathway, the effects of selective inhibitors chloroquine and baf A1 on the survival rate of suspended cells were tested. ID8-P1 cell survival was reduced from 43% to 5%, and colony formation in soft agar dropped from 90 ± 7 to 50 ± 5 (Figures 6b and c) . Injection of chloroquine (i.p.) also efficiently inhibited ID8-P1 tumor cell survival in the mouse peritoneal cavity on day 5 post injection ( Figure 6d ).
ID8-P1 cells from other organs showed similar characteristics as ID8-P1 from the PW Similar to ID8-P1 cells form PW, the additional P1 cell lines (ID8-DP-P1, ID8-OM-P1 and ID8-floating-P1) had no significant changes in cell proliferation (analyzed in attached two-dimensional tissue culture plates using MTT assays, Figure 7a 
Src-mediated anoikis resistance in in vivo passaged human EOC cells
To test whether anoikis resistance is also an important feature of aggressiveness in a similar model using human EOC cells, we compared the cell lines SKOV3 and SKOV3ip1. SKOV3ip1 cells were developed by Dr Mien-chie Hung's lab through in vivo passage of SKOV3 cells in nu/nu mice. As reported by others, SKOV3ip1 cells showed increased aggressiveness upon reinjection into naive nu/ nu mice, as compared with the parent SKOV3 cells. 11 Similar to mouse ID8-P1 cells, SKOV3ip1 cells were much more anoikis resistant than SKOV3 cells (survival rate: 64% vs 30%, Figure 8a ). In the anchorage-independent growth assay, SKOV3ip1 formed twofold more colonies than SKOV3 (31 ± 4 vs 13 ± 3, Figure 8b ). More importantly, when these cells were i.p. injected into NOD/ SCID mice (5 × 10 6 cells per mouse, n = 3), only 2 ± 1 × 10 4 SKOV3 cells, as compared with 5.6 ± 0.5 × 10 5 SKOV3ip1 cells (a 28-fold difference), survived 5 days post injection in the mouse peritoneal cavities (Figure 8c ). Finally, Src signaling was activated in suspended SKOV3ip1 cells, but not in suspended SKOV3 cells (Figure 8d) .
We also tested pSrc expression in another pair of human in vivo passaged cell lines: HEY and HEY1B. HEY1B was developed through in vivo passage of HEY cells. 12 Western blot analyses showed that Src was highly activated in HEY1B cells (Figure 8e) , and HEY1B cells were much more resistant to anoikis than HEY cells in serum-free medium (Figure 8f ). To further verify Srcmediated anoikis resistance in human ovarian cancer cell lines, we overexpressed constitutive Src (CA-Src) in OVCAR5 and OVCA 420 cells (Figure 8e ). As shown in Figures 8g and h , overexpression of CA-Src in these cells significantly improved their survival percentages in suspension condition.
DISCUSSION
More than one-third of ovarian cancer patients present with ascites at diagnosis, and almost all have ascites at recurrence.
The presence of ascites correlates with the peritoneal spread of ovarian cancer and is associated with poor disease prognosis. 13 It is well known that ascites contains large number of tumor cells and in fact, most of the established human EOC cells lines were isolated from ascites, with only a few from solid tumors. However, to our knowledge, the potential correlation and functional relationship between the numbers of floating peritoneal tumor cells and their cellular properties to disease prognosis have not been studied. Using mouse EOC syngeneic cell pairs generated via in vivo passaging, we found that enhanced anoikis resistance is a critical cellular process that correlates to tumor aggressiveness judged by time to tumor/ascites onset and morbidity. This notion is strongly supported by both in vivo and in vitro studies.
We have examined the peritoneal tumor cells survival at an early stage post injection, which recapitulates early-stage dissemination of EOC cells. It is highly significant and interesting to find that the numbers of survival floating cells are best correlated with tumor aggressiveness. This suggests that removing ascites from EOC patients is not only for reduction of patients' discomfort and burden, but also more importantly for reduction of the important source for solid tumor/metastases development. It also suggests that in addition to optimal debunking solid tumors, more complete washings to remove loosely attached or floating tumor cells in the peritoneal cavity may have clinical benefit for patients. Technically, the early-stage floating-cell counting may represent an alternative and more convenient method to analyze tumorigenesis in i.p. EOC models in vivo, when compared with the longer-time solid tumor end point method, which needs to be tested in more human and/or mouse EOC cells.
Src activation is one of the most extensively characterized oncogenic signaling pathways. It controls many cellular processes including survival. During the course of the current study, when we had already generated our ID8-P1 cell lines and independently found that Src is constitutively activated in ID8-P1 cells, Ward et al., 14 using similar approaches, reported that elevated FAK and c-Src tyrosine kinase activation are associated with ID8-IP cells when compared with parental ID8 cells.
14 However, their ID8-IP cells were derived from ascites by expansion of ascites cells after culturing under anchorage-independent conditions on lowbinding poly-HEMA-coated plates for 3-4 weeks.
14 In contrast, we isolated P1 cells from solid metastases on different organs. In addition, our isolated tumor cells were selected for transfected GFP using antibiotics, and were free of host cell contamination. The original ID8 cells were obtained through spontaneous transformation of normal ovarian surface epithelial cells from C57BL6 mice by repetitive passage in vitro. Additional passages of ID8 cells in vitro in our lab did not change their tumorigenic potential, with tumor/ascites formation requiring 80-110 days in the over 100 mice tested. In contrast, only one round of in vivo passaging markedly altered the aggressiveness of these cells, indicating that the tumor microenvironment and host cells have important roles in modulating tumor cell properties. Which host cells and/or other tumor microenvironmental factors have pivotal roles in these interactions and modifications remains to be further investigated. It is also possible that in vivo passaging effectively selects highly anoikis-resistant cells.
Although the previous work by Ward et al. 14 focused on FAK, we show here that Src is not only necessary, but also sufficient to induce anoikis resistance in EOC cells. We found that in vitro anoikis and colony formation assays, but not proliferation in twodimensional growth assays, are highly consistent with in vivo early-stage peritoneal cell survival assays in all of our functional studies, suggesting these in vitro assays recapitulate the anoikis resistance properties of tumor cells in vivo. We further show that ID8-P1 cells have increased glucose metabolism and ATP production, related to their increased Glut-1 expression, which is likely to be regulated in part by Src activation. Increased metabolism is functionally involved in anoikis resistance. Moreover, ID8-P1 cells display upregulation of several autophagic factors, which also functionally contribute to anoikis resistance.
The mouse EOC cell model has the advantage of being an immune-competent model, better representing the natural state. The potential utility of the ID8 cell/C57BL6 mouse model in human disease was demonstrated by our experiments with the human SKOV3/SKOV3ip1, and HEY/HEY1B pairs, which displayed similar oncogenic alternations in signaling pathways for anoikis resistance and Src activation.
Taken together, our studies have provided strong evidence that the level of anoikis resistance of EOC cells may be a good indicator of tumor aggressiveness in vivo, which may be conveniently analyzed at an early stage of tumor i.p. injection, or even using one of the in vitro anchorage-independent assays. This notion needs to be tested further in more EOC cells and models. More importantly, this is the first study showing that the anoikis resistance in EOC cells is likely to be a key driving process that controls disease progression and prognosis. Removing or eradicating floating tumor cells more completely, in addition to solid tumors, may have clinical benefits to EOC patients.
MATERIALS AND METHODS Materials
The following reagents were used: PP2 ( selenite. The ID8-luc cell line (expressing both GFP and luciferase) was established as described. 15 SKOV3 and SKOV3ip1 (courtesy of Dr Mien-Chie Hung, University of Texas M. D. Anderson Cancer Center) were cultured in Dulbecco's modified Eagle's medium/F12 supplemented with 4% FBS. ID8-luccells (5 × 10 6 ) were injected into the peritoneal cavity ofC57BL6 mice. Between 80 and 85 days post injection, tumor nodules on the PW were isolated and cultured with Zeocin (100 μg/ml) selection to exclude nontumor cells. The new cell lines were termed ID8-P1. All animal experiments were done under the protocols approved by Indiana University Animal Care and Use Committee.
Cell cycle analysis by flow cytometry ID8-P0 and P1 cells cultured in complete medium were collected, washed two times in phosphate-buffered saline and fixed in 75% ice-cold ethanol for 2 h. Cells were stained in 500 μl propidium iodide staining solution: 0.1% (v/v) Triton X-100 in phosphate-buffered saline with 100 μg DNAsefree RNAse A and 20 μl 500 μg/ml propidium iodide at 37°C for 15 min. Data acquisition was performed using a BD LSRII flow cytometer (San Jose, CA, USA) and analyzed by the FlowJo software (Tree Star Inc., Ashland, OR, USA).
Anoikis assays
Cells (5 × 10 5 ) were plated onto poly-HEMA-coated six-well plates (Corning, Tewksbury, MA, USA) in growth medium to prohibit attachment. After 24, 48 and 72 h in suspension, cells were transferred onto regular cell culture plates in growth medium supplemented with FBS (1%) to aid attachment. After 4 h, attached cells were trypsinized and counted using a hemocytometer. Experiments were repeated three times.
Cell survival in mouse peritoneal cavity ID8-P0 or ID8-P1 cells (5 × 10 6 ) were i.p. injected into C57BL6 mice (n = 3 per group). At several time points post injection, mice were killed and the peritoneal cavities were washed with 3 ml Dulbecco's modified Eagle's medium. The free floating tumor cells in the wash medium were counted with a hemocytometer under a fluorescent microscope (SMZ1000, Nikon, Melville, NY, USA). Dead cells were excluded by trypan blue staining.
Soft agar colony assays
Cells were suspended in 0.35% agar and seeded onto a 0.5% agar layer in 24-well plates (5 × 10 3 cells per well) in triplicate. After 2 weeks, cells were stained with crystal violet. Three fields per well were imaged and colonies were counted.
Measurement of ATP level, glucose uptake and lactate secretion
